Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON23149
NL-OMON23149
Completed
Not Applicable

Microarray Analysis in breast cancer to Tailor Adjuvant Drugs Or Regimens, a randomized phase III study.

etherlands Cancer Institute-Antoni van Leeuwenhoek Hospital0 sites660 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrimary operable breast cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary operable breast cancer
Sponsor
etherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Enrollment
660
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
etherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Women with pT1\-T3, pN0\-3b, M0 adenocarcinoma of the breast (TNM classification 2002\). Women with a macrometastasis in the sentinel node, who did not receive an axillary dissection (pN1(sn)), are only eligible if radiotherapy of the axilla is included in the treatment plan (for instance experimental arm AMAROS study);
  • •2\. Known HER2 and estrogen receptor status;

Exclusion Criteria

  • •1\. Prior systemic anticancer therapy for any cancer (immunotherapy, hormonal therapy, chemotherapy);
  • •2\. Prior radiation therapy for breast cancer;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Microarray Analysis in breast cancer to Taylor Adjuvant Drugs Or Regimens, a randomized phase III studyBreast cancerCancerBreast
ISRCTN61893718etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI AVL)664
Completed
Not Applicable
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionBreast NeoplasmsNeoplasm MetastasisGene Expression ProfilingImmunotherapy
NCT01256801Peking University Cancer Hospital & Institute36
Completed
Not Applicable
Molecular Analysis of Breast CancerBreast CancerBreast Cancer Non-invasive Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT00569049Stanford University788
Active, not recruiting
Not Applicable
Microarray Evaluaton of Normal Breast Tissue to Identify Genetic Markers of Risk for Estrogen Receptor Positive Breast CancerInvasive Breast CancerCancer - Breast
ACTRN12605000480684SSWAHS100
Recruiting
Not Applicable
Breast Cancer Subtype Characterization Through Patient's Derived Organoids.Breast CancerOrganoids
NCT06315868Fondazione Policlinico Universitario Agostino Gemelli IRCCS306